Ginkgo Bioworks (NYSE:DNA) recently released that Behzad Mahdavi, Ph.D., MBA, has joined as senior VP of biopharma manufacturing and life sciences tools. Dr. Mahdavi in this new role will lead Ginkgo’s commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities. Dr. Mahdavi has more than 20 years of expertise in the biopharmaceutical, cell and gene therapy, personalized medicine, and life sciences industries creating and directing novel patient-centric growth strategies in difficult situations.
The leading horizontal platform for cell programming,
Dr. Mahdavi most recently held the position of vice president of global open innovation at Catalent Pharma Solutions before joining Ginkgo, where he developed a distinctive range of cutting-edge services and increased the company’s clientele in new market niches. Prior to joining Catalent, he spent 13 years in several executive roles at Lonza and was CEO of SAM Electron Technologies.
Dr. Mahdavi stated in a statement that Ginkgo is merging massively scaled genetic engineering, manufacturing process optimization, and bioinformatics skills along with cutting-edge technology from outside developers. There are countless chances in this field, and he joined Ginkgo because he thinks it’s the best partner the sector could have in realizing all of those limitless possibilities. He is happy to collaborate with Ginkgo’s elite team to provide a platform of choice for its partners, who fight to improve the lives of people all across the world.
The senior VP of commercial cell engineering at Ginkgo Bioworks, Jennifer Wipf stated that Dr. Mahdavi brings outstanding experience in global business growth, expansion and commercial innovation, which will be instrumental as they aim to redefine the landscape of treating diseases. They have demonstrated how much newcomers and established players in the expanding biopharma market may benefit from their platform. Having Dr. Mahdavi on their team will increase their capacity to provide cutting-edge services to their clients as they continue to develop their horizontal platform applications, and they can’t wait to onboard additional programs in the upcoming months and years.
